Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Phototherapy | 19 | 2022 | 377 | 6.800 |
Why?
|
Wound Infection | 14 | 2020 | 242 | 4.560 |
Why?
|
Light | 23 | 2022 | 1374 | 4.090 |
Why?
|
Photochemotherapy | 31 | 2022 | 807 | 3.690 |
Why?
|
Acinetobacter baumannii | 11 | 2021 | 107 | 3.330 |
Why?
|
Photosensitizing Agents | 24 | 2022 | 602 | 3.110 |
Why?
|
Burns | 18 | 2023 | 1815 | 2.760 |
Why?
|
Anti-Infective Agents | 16 | 2023 | 974 | 2.610 |
Why?
|
Ultraviolet Therapy | 6 | 2020 | 81 | 2.530 |
Why?
|
Candida albicans | 7 | 2019 | 394 | 2.270 |
Why?
|
Quinine | 3 | 2021 | 54 | 2.250 |
Why?
|
Acinetobacter Infections | 7 | 2020 | 69 | 2.250 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 13 | 2022 | 687 | 2.070 |
Why?
|
Pseudomonas aeruginosa | 12 | 2021 | 1219 | 2.010 |
Why?
|
Candidiasis | 5 | 2019 | 366 | 1.860 |
Why?
|
Biofilms | 11 | 2024 | 617 | 1.810 |
Why?
|
Porphyrins | 5 | 2021 | 348 | 1.610 |
Why?
|
Pseudomonas Infections | 6 | 2020 | 613 | 1.470 |
Why?
|
Ultraviolet Rays | 7 | 2020 | 1060 | 1.340 |
Why?
|
Neisseria gonorrhoeae | 3 | 2019 | 238 | 1.280 |
Why?
|
Anti-Bacterial Agents | 17 | 2023 | 7182 | 1.280 |
Why?
|
Disinfection | 4 | 2020 | 191 | 1.230 |
Why?
|
Staphylococcal Skin Infections | 3 | 2020 | 75 | 1.140 |
Why?
|
Fungi | 6 | 2017 | 327 | 1.140 |
Why?
|
Bacterial Infections | 11 | 2021 | 1401 | 1.100 |
Why?
|
Mice, Inbred BALB C | 27 | 2020 | 6386 | 1.030 |
Why?
|
Chitosan | 5 | 2012 | 141 | 0.930 |
Why?
|
Mycoses | 5 | 2017 | 376 | 0.870 |
Why?
|
Microbial Viability | 3 | 2021 | 234 | 0.830 |
Why?
|
Gram-Negative Bacterial Infections | 2 | 2016 | 232 | 0.800 |
Why?
|
Pyocyanine | 1 | 2021 | 18 | 0.790 |
Why?
|
Drug Resistance, Multiple, Bacterial | 5 | 2020 | 567 | 0.780 |
Why?
|
Skin Diseases, Infectious | 1 | 2021 | 74 | 0.780 |
Why?
|
Bacteria | 7 | 2023 | 2115 | 0.750 |
Why?
|
Aspergillus fumigatus | 1 | 2021 | 150 | 0.730 |
Why?
|
Keratinocytes | 5 | 2016 | 799 | 0.730 |
Why?
|
Microbial Sensitivity Tests | 10 | 2022 | 1877 | 0.680 |
Why?
|
Bacterial Load | 1 | 2019 | 153 | 0.670 |
Why?
|
Patents as Topic | 2 | 2018 | 103 | 0.660 |
Why?
|
Drug Resistance, Bacterial | 3 | 2021 | 1035 | 0.660 |
Why?
|
Gram-Positive Bacterial Infections | 2 | 2012 | 341 | 0.660 |
Why?
|
Reactive Oxygen Species | 8 | 2023 | 2076 | 0.650 |
Why?
|
Otitis Media | 1 | 2020 | 277 | 0.610 |
Why?
|
Fullerenes | 5 | 2015 | 14 | 0.560 |
Why?
|
Skin Diseases, Bacterial | 2 | 2016 | 66 | 0.550 |
Why?
|
Communicable Diseases | 2 | 2023 | 880 | 0.540 |
Why?
|
Drug Resistance, Multiple | 3 | 2021 | 252 | 0.530 |
Why?
|
Wound Healing | 8 | 2017 | 2785 | 0.520 |
Why?
|
Skin | 8 | 2021 | 4372 | 0.520 |
Why?
|
Mice | 43 | 2023 | 81201 | 0.520 |
Why?
|
Gonorrhea | 1 | 2019 | 335 | 0.510 |
Why?
|
Disease Models, Animal | 17 | 2020 | 18034 | 0.490 |
Why?
|
Drug Resistance, Microbial | 6 | 2021 | 862 | 0.490 |
Why?
|
Animals | 56 | 2023 | 168768 | 0.480 |
Why?
|
Propionibacterium acnes | 2 | 2021 | 66 | 0.480 |
Why?
|
Bandages | 3 | 2012 | 266 | 0.470 |
Why?
|
Eye Infections, Bacterial | 1 | 2017 | 235 | 0.470 |
Why?
|
Keratitis | 1 | 2017 | 268 | 0.460 |
Why?
|
Antimalarials | 1 | 2019 | 905 | 0.430 |
Why?
|
Candidiasis, Cutaneous | 1 | 2011 | 5 | 0.410 |
Why?
|
Staphylococcal Infections | 5 | 2017 | 1400 | 0.400 |
Why?
|
Cryotherapy | 3 | 2006 | 155 | 0.380 |
Why?
|
Cornea | 2 | 2017 | 1524 | 0.380 |
Why?
|
Oxygen | 2 | 2019 | 4189 | 0.380 |
Why?
|
Coloring Agents | 2 | 2011 | 566 | 0.350 |
Why?
|
Helicobacter pylori | 1 | 2012 | 383 | 0.340 |
Why?
|
Telangiectasis | 3 | 2007 | 76 | 0.330 |
Why?
|
Wounds, Penetrating | 1 | 2011 | 307 | 0.330 |
Why?
|
Helicobacter Infections | 1 | 2012 | 387 | 0.330 |
Why?
|
Hot Temperature | 3 | 2011 | 1356 | 0.330 |
Why?
|
Laser Therapy | 5 | 2011 | 1072 | 0.330 |
Why?
|
Arthrodermataceae | 1 | 2008 | 7 | 0.330 |
Why?
|
Tolonium Chloride | 4 | 2012 | 23 | 0.330 |
Why?
|
Methylene Blue | 4 | 2013 | 155 | 0.320 |
Why?
|
Dermatomycoses | 1 | 2008 | 45 | 0.320 |
Why?
|
Onychomycosis | 1 | 2008 | 47 | 0.310 |
Why?
|
Acne Vulgaris | 1 | 2012 | 302 | 0.310 |
Why?
|
Anti-Infective Agents, Local | 1 | 2010 | 250 | 0.310 |
Why?
|
Administration, Topical | 4 | 2011 | 690 | 0.310 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2010 | 358 | 0.300 |
Why?
|
Colony Count, Microbial | 2 | 2019 | 331 | 0.300 |
Why?
|
Rabbits | 5 | 2017 | 4894 | 0.300 |
Why?
|
Antifungal Agents | 2 | 2011 | 729 | 0.300 |
Why?
|
Dose-Response Relationship, Radiation | 5 | 2012 | 876 | 0.300 |
Why?
|
Infrared Rays | 3 | 2020 | 249 | 0.290 |
Why?
|
Hydrocarbons, Fluorinated | 1 | 2006 | 39 | 0.280 |
Why?
|
Catheterization, Central Venous | 1 | 2010 | 514 | 0.270 |
Why?
|
Enterococcus faecalis | 3 | 2019 | 251 | 0.270 |
Why?
|
Proteus mirabilis | 2 | 2019 | 25 | 0.260 |
Why?
|
Silver | 3 | 2011 | 122 | 0.260 |
Why?
|
Chloramphenicol | 1 | 2023 | 75 | 0.240 |
Why?
|
Hydroxyl Radical | 1 | 2023 | 78 | 0.230 |
Why?
|
Antimicrobial Cationic Peptides | 2 | 2020 | 362 | 0.230 |
Why?
|
Epidermis | 2 | 2005 | 528 | 0.230 |
Why?
|
Infection Control | 1 | 2010 | 965 | 0.220 |
Why?
|
Lasers | 2 | 2011 | 952 | 0.220 |
Why?
|
Microscopy, Electron, Transmission | 2 | 2016 | 712 | 0.220 |
Why?
|
Blood Vessels | 2 | 2005 | 1125 | 0.220 |
Why?
|
Laser Coagulation | 1 | 2004 | 326 | 0.210 |
Why?
|
Spores, Fungal | 1 | 2021 | 94 | 0.200 |
Why?
|
Graphite | 1 | 2021 | 66 | 0.190 |
Why?
|
Ceftazidime | 1 | 2020 | 69 | 0.190 |
Why?
|
Surgical Wound Infection | 1 | 2010 | 1540 | 0.190 |
Why?
|
Curcumin | 1 | 2021 | 96 | 0.190 |
Why?
|
Luminescence | 2 | 2013 | 137 | 0.190 |
Why?
|
Plankton | 1 | 2020 | 21 | 0.180 |
Why?
|
Sodium Azide | 1 | 2019 | 24 | 0.180 |
Why?
|
Quantum Dots | 1 | 2021 | 172 | 0.180 |
Why?
|
Abetalipoproteinemia | 1 | 2019 | 17 | 0.180 |
Why?
|
Physical Phenomena | 1 | 2019 | 46 | 0.170 |
Why?
|
Polyethyleneimine | 2 | 2010 | 63 | 0.170 |
Why?
|
Humans | 48 | 2023 | 744366 | 0.170 |
Why?
|
Skin Diseases | 2 | 2006 | 1066 | 0.170 |
Why?
|
Drug Delivery Systems | 3 | 2023 | 2219 | 0.160 |
Why?
|
Arthritis, Infectious | 2 | 2013 | 367 | 0.160 |
Why?
|
Female | 29 | 2020 | 380193 | 0.160 |
Why?
|
Cryosurgery | 1 | 2003 | 453 | 0.150 |
Why?
|
Dermatologic Agents | 1 | 2021 | 278 | 0.150 |
Why?
|
Decontamination | 2 | 2019 | 69 | 0.150 |
Why?
|
Serial Passage | 1 | 2016 | 23 | 0.140 |
Why?
|
Luminescent Measurements | 2 | 2016 | 405 | 0.140 |
Why?
|
Models, Biological | 3 | 2010 | 9584 | 0.130 |
Why?
|
Sampling Studies | 1 | 2017 | 623 | 0.130 |
Why?
|
Iodides | 1 | 2015 | 41 | 0.130 |
Why?
|
Escherichia coli | 5 | 2021 | 4217 | 0.130 |
Why?
|
Nanoparticles | 2 | 2022 | 1905 | 0.130 |
Why?
|
DNA Damage | 3 | 2017 | 2432 | 0.130 |
Why?
|
Electric Stimulation Therapy | 1 | 2020 | 605 | 0.130 |
Why?
|
Shoulder Joint | 1 | 2021 | 695 | 0.130 |
Why?
|
Vagina | 1 | 2019 | 825 | 0.120 |
Why?
|
Docosahexaenoic Acids | 1 | 2020 | 875 | 0.120 |
Why?
|
Gram-Positive Bacteria | 2 | 2011 | 185 | 0.110 |
Why?
|
Treatment Outcome | 9 | 2020 | 63107 | 0.110 |
Why?
|
Bacillus megaterium | 1 | 2012 | 20 | 0.110 |
Why?
|
Bacillus cereus | 1 | 2012 | 35 | 0.110 |
Why?
|
Gram-Negative Bacteria | 2 | 2011 | 271 | 0.110 |
Why?
|
Oxazolidinones | 1 | 2013 | 96 | 0.110 |
Why?
|
Cross Infection | 1 | 2021 | 1417 | 0.110 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2016 | 1572 | 0.100 |
Why?
|
In Situ Nick-End Labeling | 1 | 2012 | 644 | 0.100 |
Why?
|
Fatty Acids | 1 | 2019 | 1809 | 0.100 |
Why?
|
Shock, Traumatic | 1 | 2011 | 22 | 0.100 |
Why?
|
Benzylidene Compounds | 1 | 2011 | 27 | 0.100 |
Why?
|
Acetamides | 1 | 2013 | 249 | 0.100 |
Why?
|
Chaperonin 60 | 1 | 2011 | 103 | 0.090 |
Why?
|
Chlorophyllides | 1 | 2010 | 53 | 0.090 |
Why?
|
Photobleaching | 1 | 2010 | 31 | 0.090 |
Why?
|
Bacteroides fragilis | 1 | 2011 | 212 | 0.090 |
Why?
|
Brain Injuries | 2 | 2013 | 2029 | 0.090 |
Why?
|
Oxidative Stress | 2 | 2019 | 3084 | 0.090 |
Why?
|
Peritoneum | 1 | 2011 | 228 | 0.090 |
Why?
|
Heat-Shock Response | 1 | 2011 | 165 | 0.090 |
Why?
|
Aerosol Propellants | 2 | 2006 | 8 | 0.090 |
Why?
|
Drug Compounding | 1 | 2011 | 242 | 0.090 |
Why?
|
Acetates | 1 | 2011 | 311 | 0.090 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14723 | 0.090 |
Why?
|
Vancomycin | 1 | 2013 | 501 | 0.090 |
Why?
|
Melanosis | 1 | 2010 | 78 | 0.090 |
Why?
|
Skin, Artificial | 1 | 2010 | 90 | 0.090 |
Why?
|
Postoperative Complications | 2 | 2011 | 15297 | 0.090 |
Why?
|
Guinea Pigs | 1 | 2011 | 1386 | 0.090 |
Why?
|
Microscopy, Electron | 1 | 2013 | 2646 | 0.090 |
Why?
|
Proteus Infections | 1 | 2008 | 10 | 0.090 |
Why?
|
Prodrugs | 1 | 2011 | 268 | 0.080 |
Why?
|
Community-Acquired Infections | 1 | 2013 | 465 | 0.080 |
Why?
|
Blood Platelets | 1 | 2019 | 2509 | 0.080 |
Why?
|
Organometallic Compounds | 1 | 2012 | 665 | 0.080 |
Why?
|
Hoof and Claw | 1 | 2008 | 12 | 0.080 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2011 | 404 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10943 | 0.080 |
Why?
|
Dimethyl Sulfoxide | 1 | 2009 | 249 | 0.080 |
Why?
|
Hypertrichosis | 1 | 2007 | 25 | 0.080 |
Why?
|
Iodine | 1 | 2010 | 286 | 0.080 |
Why?
|
Random Allocation | 1 | 2012 | 2428 | 0.080 |
Why?
|
Delayed-Action Preparations | 1 | 2011 | 968 | 0.080 |
Why?
|
Administration, Cutaneous | 1 | 2010 | 711 | 0.080 |
Why?
|
Wounds and Injuries | 1 | 2020 | 2400 | 0.070 |
Why?
|
Epithelial Cells | 1 | 2019 | 3690 | 0.070 |
Why?
|
Drug Carriers | 1 | 2011 | 693 | 0.070 |
Why?
|
Staphylococcus aureus | 2 | 2012 | 1453 | 0.070 |
Why?
|
Metal Nanoparticles | 1 | 2011 | 405 | 0.070 |
Why?
|
Sus scrofa | 1 | 2008 | 437 | 0.070 |
Why?
|
Dogs | 1 | 2011 | 3912 | 0.070 |
Why?
|
Skin Temperature | 1 | 2006 | 93 | 0.070 |
Why?
|
Nails | 1 | 2008 | 292 | 0.070 |
Why?
|
Neurogenesis | 1 | 2013 | 838 | 0.070 |
Why?
|
Rats | 3 | 2011 | 24252 | 0.070 |
Why?
|
Thigh | 1 | 2007 | 247 | 0.070 |
Why?
|
Cells, Cultured | 2 | 2012 | 19233 | 0.070 |
Why?
|
Cell Line | 1 | 2020 | 16000 | 0.070 |
Why?
|
Nevus, Pigmented | 1 | 2007 | 219 | 0.070 |
Why?
|
Neutrophils | 3 | 2013 | 3721 | 0.070 |
Why?
|
Linear Models | 1 | 2016 | 5953 | 0.070 |
Why?
|
Cicatrix, Hypertrophic | 1 | 2006 | 79 | 0.060 |
Why?
|
Inflammation | 2 | 2020 | 10637 | 0.060 |
Why?
|
Escherichia coli Proteins | 1 | 2011 | 1050 | 0.060 |
Why?
|
Indoles | 1 | 2012 | 1839 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2011 | 1677 | 0.060 |
Why?
|
Regeneration | 1 | 2012 | 1485 | 0.060 |
Why?
|
Radiotherapy Dosage | 2 | 2011 | 2879 | 0.050 |
Why?
|
Aerosols | 1 | 2005 | 625 | 0.050 |
Why?
|
Colon | 1 | 2011 | 1772 | 0.050 |
Why?
|
Cell Survival | 1 | 2012 | 5882 | 0.050 |
Why?
|
Therapy, Computer-Assisted | 1 | 2004 | 271 | 0.050 |
Why?
|
Hyperthermia, Induced | 1 | 2006 | 403 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3135 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3242 | 0.050 |
Why?
|
Benzoyl Peroxide | 1 | 2021 | 18 | 0.050 |
Why?
|
Arthritis | 1 | 2007 | 661 | 0.050 |
Why?
|
Body Temperature | 1 | 2004 | 777 | 0.050 |
Why?
|
Up-Regulation | 3 | 2019 | 4222 | 0.050 |
Why?
|
Dentistry | 1 | 2021 | 113 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2017 | 21833 | 0.050 |
Why?
|
Apoptosis | 2 | 2016 | 9724 | 0.050 |
Why?
|
Swine | 1 | 2011 | 5918 | 0.050 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2020 | 143 | 0.050 |
Why?
|
Trauma Severity Indices | 1 | 2003 | 481 | 0.050 |
Why?
|
Immunity, Innate | 1 | 2012 | 2962 | 0.050 |
Why?
|
Chlorhexidine | 1 | 2021 | 162 | 0.050 |
Why?
|
Solubility | 2 | 2012 | 1088 | 0.040 |
Why?
|
Colonic Neoplasms | 1 | 2011 | 2542 | 0.040 |
Why?
|
Cell Wall | 1 | 2022 | 422 | 0.040 |
Why?
|
Radiation Injuries | 1 | 2006 | 1180 | 0.040 |
Why?
|
Blood Preservation | 1 | 2019 | 177 | 0.040 |
Why?
|
Models, Animal | 1 | 2005 | 2173 | 0.040 |
Why?
|
Tachycardia | 1 | 2020 | 619 | 0.040 |
Why?
|
Lasers, Solid-State | 1 | 2020 | 169 | 0.040 |
Why?
|
Pneumonia, Bacterial | 1 | 2020 | 316 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39052 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9445 | 0.030 |
Why?
|
Genes, Bacterial | 1 | 2019 | 1079 | 0.030 |
Why?
|
Survival Analysis | 1 | 2008 | 10252 | 0.030 |
Why?
|
Nanostructures | 1 | 2020 | 551 | 0.030 |
Why?
|
Fluorescent Dyes | 2 | 2013 | 1917 | 0.030 |
Why?
|
Consensus | 1 | 2024 | 2960 | 0.030 |
Why?
|
Tetrapyrroles | 1 | 2013 | 3 | 0.030 |
Why?
|
Keratin-14 | 1 | 2013 | 57 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2011 | 6364 | 0.030 |
Why?
|
Drug Antagonism | 1 | 2013 | 50 | 0.030 |
Why?
|
Neurons | 1 | 2013 | 9340 | 0.030 |
Why?
|
Joint Capsule | 1 | 2013 | 69 | 0.030 |
Why?
|
Fluoresceins | 1 | 2013 | 235 | 0.030 |
Why?
|
Photochemical Processes | 1 | 2012 | 84 | 0.030 |
Why?
|
Optical Phenomena | 1 | 2013 | 107 | 0.030 |
Why?
|
Bromodeoxyuridine | 1 | 2013 | 322 | 0.030 |
Why?
|
Free Radicals | 1 | 2012 | 237 | 0.030 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2013 | 285 | 0.030 |
Why?
|
Electron Transport | 1 | 2012 | 211 | 0.030 |
Why?
|
Injections, Intra-Articular | 1 | 2013 | 278 | 0.030 |
Why?
|
Stomach Ulcer | 1 | 2011 | 125 | 0.020 |
Why?
|
Computer Simulation | 1 | 2004 | 6194 | 0.020 |
Why?
|
Pandemics | 2 | 2021 | 8385 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2011 | 425 | 0.020 |
Why?
|
Arthritis, Experimental | 1 | 2013 | 291 | 0.020 |
Why?
|
Micelles | 1 | 2011 | 203 | 0.020 |
Why?
|
Cations | 1 | 2010 | 232 | 0.020 |
Why?
|
Candida | 1 | 2010 | 172 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2020 | 3511 | 0.020 |
Why?
|
Male | 10 | 2021 | 350115 | 0.020 |
Why?
|
Signal Transduction | 1 | 2012 | 23404 | 0.020 |
Why?
|
Pyrrolidines | 1 | 2011 | 342 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 2007 | 5692 | 0.020 |
Why?
|
Dental Caries | 1 | 2011 | 415 | 0.020 |
Why?
|
Zymosan | 1 | 2007 | 124 | 0.020 |
Why?
|
Virus Diseases | 1 | 2013 | 711 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2013 | 10483 | 0.020 |
Why?
|
Sepsis | 1 | 2020 | 2593 | 0.020 |
Why?
|
Species Specificity | 1 | 2011 | 2478 | 0.020 |
Why?
|
Periodontitis | 1 | 2011 | 553 | 0.020 |
Why?
|
Erythema | 1 | 2007 | 257 | 0.020 |
Why?
|
HeLa Cells | 1 | 2012 | 3130 | 0.020 |
Why?
|
Water | 1 | 2012 | 1395 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 2007 | 1162 | 0.020 |
Why?
|
Pigmentation | 1 | 2006 | 148 | 0.020 |
Why?
|
Fibrosis | 1 | 2012 | 2029 | 0.020 |
Why?
|
Drug Design | 1 | 2011 | 1076 | 0.020 |
Why?
|
Time Factors | 2 | 2007 | 40075 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2011 | 2027 | 0.020 |
Why?
|
Abdomen | 1 | 2011 | 1118 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2010 | 3130 | 0.020 |
Why?
|
Down-Regulation | 1 | 2012 | 3001 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2013 | 1881 | 0.020 |
Why?
|
Dinoprostone | 1 | 2007 | 601 | 0.020 |
Why?
|
Face | 1 | 2010 | 994 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2012 | 1707 | 0.010 |
Why?
|
Edema | 1 | 2007 | 789 | 0.010 |
Why?
|
Adult | 4 | 2021 | 214052 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6489 | 0.010 |
Why?
|
Motor Activity | 1 | 2013 | 2715 | 0.010 |
Why?
|
Neck | 1 | 2006 | 698 | 0.010 |
Why?
|
Middle Aged | 5 | 2010 | 213390 | 0.010 |
Why?
|
Atrophy | 1 | 2006 | 1584 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8642 | 0.010 |
Why?
|
Polysaccharides | 1 | 2007 | 1059 | 0.010 |
Why?
|
Hypothermia, Induced | 1 | 2005 | 752 | 0.010 |
Why?
|
Dexamethasone | 1 | 2007 | 1951 | 0.010 |
Why?
|
Papillomavirus Infections | 1 | 2011 | 1587 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11366 | 0.010 |
Why?
|
Blood Coagulation | 1 | 2005 | 1127 | 0.010 |
Why?
|
Cytokines | 1 | 2013 | 7323 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2007 | 1790 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 13035 | 0.010 |
Why?
|
Research Design | 1 | 2013 | 5984 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 16690 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2012 | 19905 | 0.010 |
Why?
|
United States | 1 | 2021 | 69872 | 0.010 |
Why?
|
Depression | 1 | 2011 | 7759 | 0.010 |
Why?
|
Aged | 1 | 2003 | 163288 | 0.010 |
Why?
|
Brain | 1 | 2011 | 26388 | 0.000 |
Why?
|
Adolescent | 1 | 2007 | 85779 | 0.000 |
Why?
|